BLCO: third-quarter revenue up 7% as company raises fiscal 2026 outlook
Bausch + Lomb reported higher third-quarter revenue and profit across all segments and raised its FY26 revenue and adjusted EBITDA guidance, according to TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, Bausch + Lomb (BLCO) posted third-quarter revenue growth of 7% as reported and 8% in constant currency. Every segment contributed to the increase, and operating income rose as well.
Adjusted EBITDA climbed to $325 million, up 34%. Citing the strong third quarter and a stronger expected finish to the year, the company raised its guidance for fiscal 2026 revenue and adjusted EBITDA.
why it matters
For investors, the key point is that growth was broad-based rather than driven by one segment, and that the outlook moved higher. This could support interest in BLCO shares and in medical device peers, though these figures come from a TradingView summary that itself flags possible inaccuracies.
market impact
BLCO shares: strong results and a higher outlook support investor expectations
- BLCO pressure up — revenue and profit growth with a raised outlook supports interest in the stock
tags
instruments
sources
- BLCO: Broad-based Q3 growth lifted profitability and prompted higher FY26 guidance — TradingView, 28 October 2026 at 11:09 UTC
- BLCO: Broad-based growth lifted Q3 earnings and raised FY26 guidance — TradingView, 28 October 2026 at 11:07 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗